# Treatment Effect of Mometasone Furoate Cream on Lichen Sclerosus et Atrophicus of External Genitalia in Boys and Its Correlation with Toll-Like Receptor 4 and Myeloid Differentiation Factor 88

Authors: Hong Sun; Wei Zhang; Guibo Wang; Chuanwei Sun; Yan Liang; Aijun Li; Qingfeng Li; Jie Lei
Journal: Journal of Healthcare Engineering
 (2022)

---

## Abstract

Objective. The objective is to explore the treatment effect of mometasone furoate cream on lichen sclerosus et atrophicus (LSeA) of external genitalia in boys and its correlation with Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88). Methods. A total of 100 boys treated in our hospital from January 2021 to January 2023 due to clinical manifestations in the external genitalia were selected as the study objects. All boys received redundant circumcision treatment, their protein expression of TLR4 and MyD88 in foreskin tissues was measured by BCA protein assay and western blot, and mometasone furoate cream was applied to those who were pathologically diagnosed with LSeA, so as to compare the levels of serum inflammatory factors and urodynamic indicators in the child patients before and after treatment. Results. The total clinical efficacy rate of LSeA child patients was up to 90.79%; after treatment, the maximum and mean urinary flow rates of child patients were significantly higher than before treatment P<0.001; compared with the non-LSeA group, the protein expression of TLR4, MyD88, and NF-κB was increased in the LSeA group P<0.001, and the mRNA expression of TLR4, MyD88, and NF-κB was significantly increased in the LSeA group P<0.001; the results of ROC curves showed that TLR4 had the highest AUC value, and during treatment, the incidence rate of adverse reactions in child patients was 6.58%. Conclusion. LSeA will increase the inflammatory reactions in child patients, and its pathogenesis may be related to the upregulation of TLR4, MyD88, NF-κB expression and thus activation of TLR4/MyD88/NF-κB signaling pathways. Applying mometasone furoate cream to LSeA patients after redundant circumcision can effectively reduce the inflammatory reactions in the body and improve their urodynamic indicators, with exact efficacy. Further research will be conducive to establishing a better treatment scheme for such child patients.


---

## Body

## 1. Introduction

Lichen sclerosus et atrophicus (LSeA), an inflammatory cell-mediated chronic skin disease with unknown etiology [1], often arises around the anus and genitalia and is much more prevalent in women than in men, with a male/female incidence ratio of 1 : 10 and the predilection age of 40–50 years. Senior men and boys are the two male populations vulnerable to the disease, and children of 9–12 years have a higher incidence rate. Clinical studies have shown [2] that inheritance, autoimmunity, humid environment, local infection, trauma, and obstruction are all risk factors predisposing to LSeA. In recent years, some scholars have proposed [3] the concept of LSeA of the external genitalia in boys, increasing people’s awareness of this disease. Early LSeA of the external genitalia in boys involves in the prepuce, and as the disease progresses further, the inner plate of prepuce will exhibit patches fusing into pieces with a stiff texture and poor elasticity, forming a scared stenosis ring, so the prepuce tightly adheres to the glans penis with separation difficulty, which ultimately leads to dysuria [4, 5]. Redundant circumcision is the most common type of urological surgery and is the current common surgical method for treating LSeA in men, but patients still show much urethral orifice secretions after surgery and even local symptom manifestations such as desquamation [6]; hence, the implementation of postoperative intervention in patients undergoing redundant circumcision is the key to improve the prognosis of the disease. It has been reported [7] that the clinical and pathological manifestation of LSeA is a lymphocyte-mediated chronic inflammatory cell infiltration leading to severely fibrotic lesions of the epithelium. Mometasone furoate cream, a topical drug that has multiple effects such as immunosuppression, anti-inflammation, and antihyperplasia, is featured with fast onset and good skin tolerability and easily accepted by patients and is commonly used to treat skin diseases such as neurologic rash and eczema [8] with good results, and its efficacy has been demonstrated in children with phimosis [9]. In addition, biological mechanism found that Toll-like receptor 4 (TLR4) plays an important role in the process of inflammation and immune response. TLR4 is the protein that mediates the stimulation of biotic or abiotic sources and opens the portal of inflammatory response in the body [10], which is a significant receptor related to the trans-membrane signaling of bacterial lipopolysaccharide in Gram-negative bacteria. As shown by research reports [11], the up-regulated expression level of TLR4 can activate inflammatory response mechanisms and the immune system in the body, induce apoptosis of cardiac muscle cells, leading to myocardial remodeling, aggravate cardiac structural and functional damage, and play an important role in the development and progression of chronic heart failure. Myeloid differentiation factor 88 (MyD88) is a key adaptor molecule in the Toll-like receptor (TLR) signaling pathway [12], which exerts the vital function in transmitting upstream messages and disease initiation and progression. TLR4 and MyD88, the inflammasome activation or innate immune pathway, are addressed in several studies and reviews [13]. However, there are no studies confirming the treatment effect of mometasone furoate cream on LSeA of external genitalia in boys and its correlation with TLR4 and MyD88. Therefore, the treatment effect obtained in this study can be promoted as a clinical diagnosis basis to alleviate the illness in child patients, understand relevant molecular mechanism and pathogenesis, and offer guidance for clinical treatment.


## 2. Materials and Methods

### 2.1. Case Selection

A total of 100 boys were treated in our hospital from January 2021 to January 2023 due to clinical manifestations in the external genitalia (e.g., stricture of the urethral orifice, failure to evert and expose the urethral orifice, white spots, and obvious scar at the preputial orifice in some cases, leading to weak stream of urine and dysuria) were selected as the study objects, and they were aged 3–14 years. The study met the World Medical Association Declaration of Helsinki [14].


### 2.2. Methods

All child patients received the redundant circumcision therapy. Local infiltration anesthesia was performed at the penile base by administrating 0.5 ml of lidocaine hydrochloride injection (manufacturer: Shanghai Zhaohui Pharmaceutical Co., Ltd.; NMPA approval no. H31021072; specification: 5 ml: 0.1 g) via subcutaneous annular injection. Urinary flow rate was measured before surgery, the prepuce tissues were sent for pathological examination after surgery, and the urinary flow rate was remeasured 1 month after surgery. For child patients who were pathologically diagnosed with LSeA, 0.1% mometasone furoate cream (manufacturer: Bayer HealthCare Co., Ltd.; NMPA approval no. H19991418; specification: 5 g:5 mg) was applied locally. Partial prepuce tissues of LSeA cases and non-LSeA cases were measured by BCA protein assay and western blot, so as to further clarify the protein expression of TLR4 and MyD88 in child patients of the two groups.


### 2.3. Observation Indicators

Efficacy determination. Cured: various clinical symptoms of child patients disappeared after treatment, and the result of fungus microscope examination and culture was negative; markedly effective: the clinical symptoms were alleviated, extinction of skin lesion ≥60%, and the result of fungus microscope examination and culture was negative; improved: the clinical symptoms were alleviated, extinction of skin lesion ≥20%, and the result of fungus microscope examination and culture was positive; ineffective: no reduction or even aggravation of clinical symptoms, extinction of skin lesion <20%, and the result of fungus microscope examination and culture was positive. The total efficacy rate = (number of cured cases + number of markedly effective cases)/total number of cases∗ 100%.Various urodynamic indicators of child patients before and after treatment were measured. First, a routine urine test was carried out to check if the child patients had urinary tract infection symptoms, and if not, the measurement could be conducted. The child patients were lying in the examination bed with the two legs separated at 90° to fully expose the external genitalia, and after external disinfection using iodophor, a manometric tube was directly inserted through the urethra into the bladder and externally connected to the urodynamic instrument (model: ZN999-Nidoc970A; manufacturer: Beijing Haifuda Technology Co., Ltd.). Once the tubing was connected, the urine in the bladder was completely emptied, and the instrument automatically instilled sterile saline into the bladder at a rate determined by the patients’ tolerance, at which time the child patients’ maximum and mean urinary flow rates and effective voiding time were recorded by the instrument.Four ml of fasting venous blood was drawn from the LSeA child patients before and after treatment to make the serum specimens and then measure the level values of serum interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-α (TNF-α) by ELISA method, with the kits purchased from Nanjing Sbjbio Technology Co., Ltd.The postoperative prepuce tissues of child patients were put into the electric homogenizer for homogenization; the protein lysis buffer and phenylmethylsulfonyl fluoride with a final concentration of 1 mmol/L (manufacturer: Beyotime Biotechnology; item no. ST506) were added; proper amount of tissues was taken and put into the cell lysis buffer, then fully ground by the tissue lyser (manufacturer: Shanghai Jingxin Science & Technology Co., Ltd.; item no. Tissuelyser-24), and lysed on ice for 10 min and centrifuged for 10 min at 12,000 × g, and the supernatant was extracted for protein quantification measurement with the BCA protein assay kit (manufacturer: Beyotime Biotechnology; item no. P0010S). Taking the lowest concentration as the standard, after a certain amount of lysis buffer was added to adjust the proteins of each group to the equal concentration, the proteins were diluted with the equal volume of SDS-PAGE sample loading buffer (1X) (manufacturer: Beyotime Biotechnology; item no. P0015A), and then, the protein specimens were taken for sodium dodecyl sulphate (manufacturer: Meilunbio; item no. P0015A)-polyacrylamide gel electrophoresis (SDS-PAGE) to separate the protein. The proteins on the gel were then transferred onto the 0.22μm polyvinylidene fluoride (PVDF) membrane (320 mA for 1.5 h), with the transfer electric current set as 250 mA and transfer time of 60–120 min. After membrane trafficking, the proteins were blocked by 5% skim milk powder for 1 h under room temperature, and the diluent of TLR4, MyD88, NF-κB, and GAPDH primary antibody diluted at 1 : 1,000 (manufacturer: Servicebio; item no. G2025) was added for incubation overnight under 4°C or over 2 h under 37°C. After incubation, the membranes were rinsed 3 times with 1 × TBST, 10 min each time. The secondary antibody diluent (manufacturer: Servicebio; item no. G2009) was added, and the membranes were placed on the shaking table (manufacturer: SCILOGEN; model: SK-L180-E) for 1 h incubation under room temperature, and then, the membranes were rinsed 3 times with 1 × TBST, 10 min each time. The PVDF membranes were put into the chemiluminescence apparatus, and the exposure fluids A and B were mixed by a ratio of 1 : 1 and then dropped on the membranes evenly for exposure. The images were analyzed with Image J, and the results were expressed as the ratio of the optical density of the target protein to the internal reference protein GAPDH.RT-PCR: partial prepuce tissues were excised from child patients in the two groups, put into the liquid nitrogen, and ground into powder; the total RNA was extracted and measured for the concentration; cDNA was synthesized according to the specification on the kits in a total reaction volume of 20μl; the reverse transcription conditions were 30 min at 25°C, 30 min at 42°C, and 30 min at 85°C. 2 μl of cDNA template was taken for expansion in vitro according to the expansion specification of real-time PCR in a total reaction volume of 20 μl; the expansion condition was 5 min degeneration at 95°C. With β-actin being the internal reference, the Ct value of each group was obtained, and the amount of gene expression was analyzed by the 2−△△Ct method. The primer sequences were as follows: TLR4 upstream region: 5ʹ-TAG CCA TTG CTG CCA ACA TC-3′; downstream region: 5ʹ-ACA CCA ACG GCT CTG GAT AA-3ʹ; MyD88 upstream region: 5ʹ-GCA TGG TGG TGG TTG TTTCT-3′; downstream region: 5′-TCT GTT GGA CAC CTG GAG AC-3ʹ; NF-kβ upstream region: 5′-AAG ATC TGC CGA GTAAAC CG-3′; downstream region: 5ʹ-TCC CGT GAA ATA CAC CTCAA-3ʹ; β-actin upstream region: 5′-CTT CAT TGA CCT CAACTA CAT GG-3′; downstream region: 5ʹ-CTC GCT CCT GGA AGATGG TGA T-3ʹ.The occurrence of adverse reactions in child patients during treatment was recorded and compared.


### 2.4. Statistical Methods

In this study, the data were processed by the professional statistic software SPSS26.0, the picture drawing software was GraphPad Prism 7 (GraphPad Software, San Diego, USA), the enumeration data were examined byX2 test and expressed by [n(%)], the measurement data were examined by t-test and expressed by mean ± SD, the correlation was analyzed by Pearson method and plotting ROC curves, and differences were considered statistically significant at P<0.05.


## 2.1. Case Selection

A total of 100 boys were treated in our hospital from January 2021 to January 2023 due to clinical manifestations in the external genitalia (e.g., stricture of the urethral orifice, failure to evert and expose the urethral orifice, white spots, and obvious scar at the preputial orifice in some cases, leading to weak stream of urine and dysuria) were selected as the study objects, and they were aged 3–14 years. The study met the World Medical Association Declaration of Helsinki [14].


## 2.2. Methods

All child patients received the redundant circumcision therapy. Local infiltration anesthesia was performed at the penile base by administrating 0.5 ml of lidocaine hydrochloride injection (manufacturer: Shanghai Zhaohui Pharmaceutical Co., Ltd.; NMPA approval no. H31021072; specification: 5 ml: 0.1 g) via subcutaneous annular injection. Urinary flow rate was measured before surgery, the prepuce tissues were sent for pathological examination after surgery, and the urinary flow rate was remeasured 1 month after surgery. For child patients who were pathologically diagnosed with LSeA, 0.1% mometasone furoate cream (manufacturer: Bayer HealthCare Co., Ltd.; NMPA approval no. H19991418; specification: 5 g:5 mg) was applied locally. Partial prepuce tissues of LSeA cases and non-LSeA cases were measured by BCA protein assay and western blot, so as to further clarify the protein expression of TLR4 and MyD88 in child patients of the two groups.


## 2.3. Observation Indicators

Efficacy determination. Cured: various clinical symptoms of child patients disappeared after treatment, and the result of fungus microscope examination and culture was negative; markedly effective: the clinical symptoms were alleviated, extinction of skin lesion ≥60%, and the result of fungus microscope examination and culture was negative; improved: the clinical symptoms were alleviated, extinction of skin lesion ≥20%, and the result of fungus microscope examination and culture was positive; ineffective: no reduction or even aggravation of clinical symptoms, extinction of skin lesion <20%, and the result of fungus microscope examination and culture was positive. The total efficacy rate = (number of cured cases + number of markedly effective cases)/total number of cases∗ 100%.Various urodynamic indicators of child patients before and after treatment were measured. First, a routine urine test was carried out to check if the child patients had urinary tract infection symptoms, and if not, the measurement could be conducted. The child patients were lying in the examination bed with the two legs separated at 90° to fully expose the external genitalia, and after external disinfection using iodophor, a manometric tube was directly inserted through the urethra into the bladder and externally connected to the urodynamic instrument (model: ZN999-Nidoc970A; manufacturer: Beijing Haifuda Technology Co., Ltd.). Once the tubing was connected, the urine in the bladder was completely emptied, and the instrument automatically instilled sterile saline into the bladder at a rate determined by the patients’ tolerance, at which time the child patients’ maximum and mean urinary flow rates and effective voiding time were recorded by the instrument.Four ml of fasting venous blood was drawn from the LSeA child patients before and after treatment to make the serum specimens and then measure the level values of serum interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-α (TNF-α) by ELISA method, with the kits purchased from Nanjing Sbjbio Technology Co., Ltd.The postoperative prepuce tissues of child patients were put into the electric homogenizer for homogenization; the protein lysis buffer and phenylmethylsulfonyl fluoride with a final concentration of 1 mmol/L (manufacturer: Beyotime Biotechnology; item no. ST506) were added; proper amount of tissues was taken and put into the cell lysis buffer, then fully ground by the tissue lyser (manufacturer: Shanghai Jingxin Science & Technology Co., Ltd.; item no. Tissuelyser-24), and lysed on ice for 10 min and centrifuged for 10 min at 12,000 × g, and the supernatant was extracted for protein quantification measurement with the BCA protein assay kit (manufacturer: Beyotime Biotechnology; item no. P0010S). Taking the lowest concentration as the standard, after a certain amount of lysis buffer was added to adjust the proteins of each group to the equal concentration, the proteins were diluted with the equal volume of SDS-PAGE sample loading buffer (1X) (manufacturer: Beyotime Biotechnology; item no. P0015A), and then, the protein specimens were taken for sodium dodecyl sulphate (manufacturer: Meilunbio; item no. P0015A)-polyacrylamide gel electrophoresis (SDS-PAGE) to separate the protein. The proteins on the gel were then transferred onto the 0.22μm polyvinylidene fluoride (PVDF) membrane (320 mA for 1.5 h), with the transfer electric current set as 250 mA and transfer time of 60–120 min. After membrane trafficking, the proteins were blocked by 5% skim milk powder for 1 h under room temperature, and the diluent of TLR4, MyD88, NF-κB, and GAPDH primary antibody diluted at 1 : 1,000 (manufacturer: Servicebio; item no. G2025) was added for incubation overnight under 4°C or over 2 h under 37°C. After incubation, the membranes were rinsed 3 times with 1 × TBST, 10 min each time. The secondary antibody diluent (manufacturer: Servicebio; item no. G2009) was added, and the membranes were placed on the shaking table (manufacturer: SCILOGEN; model: SK-L180-E) for 1 h incubation under room temperature, and then, the membranes were rinsed 3 times with 1 × TBST, 10 min each time. The PVDF membranes were put into the chemiluminescence apparatus, and the exposure fluids A and B were mixed by a ratio of 1 : 1 and then dropped on the membranes evenly for exposure. The images were analyzed with Image J, and the results were expressed as the ratio of the optical density of the target protein to the internal reference protein GAPDH.RT-PCR: partial prepuce tissues were excised from child patients in the two groups, put into the liquid nitrogen, and ground into powder; the total RNA was extracted and measured for the concentration; cDNA was synthesized according to the specification on the kits in a total reaction volume of 20μl; the reverse transcription conditions were 30 min at 25°C, 30 min at 42°C, and 30 min at 85°C. 2 μl of cDNA template was taken for expansion in vitro according to the expansion specification of real-time PCR in a total reaction volume of 20 μl; the expansion condition was 5 min degeneration at 95°C. With β-actin being the internal reference, the Ct value of each group was obtained, and the amount of gene expression was analyzed by the 2−△△Ct method. The primer sequences were as follows: TLR4 upstream region: 5ʹ-TAG CCA TTG CTG CCA ACA TC-3′; downstream region: 5ʹ-ACA CCA ACG GCT CTG GAT AA-3ʹ; MyD88 upstream region: 5ʹ-GCA TGG TGG TGG TTG TTTCT-3′; downstream region: 5′-TCT GTT GGA CAC CTG GAG AC-3ʹ; NF-kβ upstream region: 5′-AAG ATC TGC CGA GTAAAC CG-3′; downstream region: 5ʹ-TCC CGT GAA ATA CAC CTCAA-3ʹ; β-actin upstream region: 5′-CTT CAT TGA CCT CAACTA CAT GG-3′; downstream region: 5ʹ-CTC GCT CCT GGA AGATGG TGA T-3ʹ.The occurrence of adverse reactions in child patients during treatment was recorded and compared.


## 2.4. Statistical Methods

In this study, the data were processed by the professional statistic software SPSS26.0, the picture drawing software was GraphPad Prism 7 (GraphPad Software, San Diego, USA), the enumeration data were examined byX2 test and expressed by [n(%)], the measurement data were examined by t-test and expressed by mean ± SD, the correlation was analyzed by Pearson method and plotting ROC curves, and differences were considered statistically significant at P<0.05.


## 3. Results

### 3.1. Efficacy Evaluation

According to the results of postoperative histopathological diagnosis, there were 24 non-LSeA child patients and 76 LSeA child patients. Among the LSeA child patients, the cured rate was 71.05% (54/76), the markedly effective rate was 19.74% (15/76), the improved rate was 7.89% (6/76), the ineffective rate was 1.32% (1/76), and the total clinical efficacy rate was 90.79% (69/76).


### 3.2. Comparison of Various Urodynamic Indicators

After treatment, the maximum and mean urinary flow rates of child patients were significantly higher than before treatmentP<0.001, and the effective voiding time was lower than before treatment P<0.001 (see Table 1).Table 1
Comparison of child patients’ various urodynamic indicators before and after treatment (mean ± SD).
TimeNMaximum urinary flow rate (mL/s)Mean urinary flow rate (mL/s)Effective voiding time (s)Before treatment7612.92 ± 2.655.26 ± 0.7720.54 ± 1.83After treatment7620.60 ± 2.5410.28 ± 1.2611.96 ± 1.30T18.24029.63733.322P<0.001<0.001<0.001


### 3.3. Inflammatory Factors

After treatment, the levels of various inflammatory factors in LSeA child patients were significantly lower than before treatmentP<0.001 (see Table 2).Table 2
Comparison of child patients’ levels of inflammatory factors before and after treatment (mean ± SD).
TimenIL-6 (pg·mL−1)IL-17 (pg·mL−1)TNF-α (pg·mL−1)Before treatment7665.89 ± 4.78134.13 ± 10.52107.31 ± 7.35After treatment7625.48 ± 2.6486.85 ± 6.0362.34 ± 5.59t64.51433.99242.455P<0.001<0.001<0.001


### 3.4. Protein Expression of TLR4, MyD88, and NF-κB in Child Patients’ Prepuce Tissues

Compared with the non-LSeA group, the protein expression of TLR4, MyD88, and NF-κB was increased in LSeA group P<0.001 (see Figure 1).Figure 1
Protein expression of TLR4, MyD88, and NF-κB in child patients’ prepuce tissues (mean ± SD). Note: the horizontal axis indicated the TLR4, MyD88, and NF-κB, and the vertical axis indicated the relative protein expression; the relative protein expression of TLR4, MyD88, and NF-κB in non-LSeA child patients was, respectively, 1.05 ± 0.03, 1.07 ± 0.04, and 1.04 ± 0.02; the relative protein expression of TLR4, MyD88, and NF-κB in LSeA child patients was, respectively, 2.67 ± 0.05, 1.89 ± 0.03, and 2.11 ± 0.04; ∗indicated a significant difference in the relative expression of TLR4 between the two groups (t = 48.121, P<0.001); ∗∗indicated a significant difference in the relative expression of MyD88 between the two groups (t = 28.406, P<0.001); and ∗∗∗indicated a significant difference in the relative expression of NF-κB between the two groups (t = 41.441, P<0.001).


### 3.5. MRNA Expression of TLR4, MyD88, and NF-κB in Child Patients’ Prepuce Tissue

Compared with the non-LSeA group, the mRNA expression of TLR4, MyD88, and NF-κB was increased in the LSeA group P<0.001, with the variation trend consistent with the western blot results (see Figure 2).Figure 2
MRNA expression of TLR4, MyD88, and NF-κB in child patients’ prepuce tissues (mean ± SD). Note: the horizontal axis indicated TLR4, MyD88, and NF-κB, and the vertical axis indicated the mRNA expression; the mRNA expression of TLR4, MyD88, and NF-κB in non-LSeA child patients was, respectively, 0.99 ± 0.02, 1.02 ± 0.02, and 1.12 ± 0.06; the mRNA expression of TLR4, MyD88, and NF-κB in LSeA child patients was, respectively, 2.06 ± 0.10, 1.75 ± 0.22, and 1.68 ± 0.21; ∗ indicated a significant difference in the relative expression of TLR4 between the two groups (t = 51.920, P<0.001); ∗∗ indicated a significant difference in the relative expression of MyD88 between the two groups (t = 16.179, P<0.001); and ∗∗∗ indicated a significant difference in the relative expression of NF-κB between the two groups (t = 12.859, P<0.001).


### 3.6. ROC Curve Results of LSeA Predicted by Each Index

The results showed that TLR4 had the highest AUC value (see Figure3 and Table 3).Figure 3
ROC curves of LSeA predicted by each index.Table 3
ROC curve results of LSeA predicted by each index.
Test result variableAUCSEaAsymp.sigbAsymp.95%CILower limitUpper limitTLR40.8230.0540.0000.7180.929MyD880.7070.0640.0000.5810.833NF-κB0.7360.0610.0000.6160.855


### 3.7. Adverse Reactions

During the treatment, 2 patients had burning sensation and 3 patients had nausea in the LSeA group, and the total incidence rate of adverse reactions was 6.58% (5/76).


## 3.1. Efficacy Evaluation

According to the results of postoperative histopathological diagnosis, there were 24 non-LSeA child patients and 76 LSeA child patients. Among the LSeA child patients, the cured rate was 71.05% (54/76), the markedly effective rate was 19.74% (15/76), the improved rate was 7.89% (6/76), the ineffective rate was 1.32% (1/76), and the total clinical efficacy rate was 90.79% (69/76).


## 3.2. Comparison of Various Urodynamic Indicators

After treatment, the maximum and mean urinary flow rates of child patients were significantly higher than before treatmentP<0.001, and the effective voiding time was lower than before treatment P<0.001 (see Table 1).Table 1
Comparison of child patients’ various urodynamic indicators before and after treatment (mean ± SD).
TimeNMaximum urinary flow rate (mL/s)Mean urinary flow rate (mL/s)Effective voiding time (s)Before treatment7612.92 ± 2.655.26 ± 0.7720.54 ± 1.83After treatment7620.60 ± 2.5410.28 ± 1.2611.96 ± 1.30T18.24029.63733.322P<0.001<0.001<0.001


## 3.3. Inflammatory Factors

After treatment, the levels of various inflammatory factors in LSeA child patients were significantly lower than before treatmentP<0.001 (see Table 2).Table 2
Comparison of child patients’ levels of inflammatory factors before and after treatment (mean ± SD).
TimenIL-6 (pg·mL−1)IL-17 (pg·mL−1)TNF-α (pg·mL−1)Before treatment7665.89 ± 4.78134.13 ± 10.52107.31 ± 7.35After treatment7625.48 ± 2.6486.85 ± 6.0362.34 ± 5.59t64.51433.99242.455P<0.001<0.001<0.001


## 3.4. Protein Expression of TLR4, MyD88, and NF-κB in Child Patients’ Prepuce Tissues

Compared with the non-LSeA group, the protein expression of TLR4, MyD88, and NF-κB was increased in LSeA group P<0.001 (see Figure 1).Figure 1
Protein expression of TLR4, MyD88, and NF-κB in child patients’ prepuce tissues (mean ± SD). Note: the horizontal axis indicated the TLR4, MyD88, and NF-κB, and the vertical axis indicated the relative protein expression; the relative protein expression of TLR4, MyD88, and NF-κB in non-LSeA child patients was, respectively, 1.05 ± 0.03, 1.07 ± 0.04, and 1.04 ± 0.02; the relative protein expression of TLR4, MyD88, and NF-κB in LSeA child patients was, respectively, 2.67 ± 0.05, 1.89 ± 0.03, and 2.11 ± 0.04; ∗indicated a significant difference in the relative expression of TLR4 between the two groups (t = 48.121, P<0.001); ∗∗indicated a significant difference in the relative expression of MyD88 between the two groups (t = 28.406, P<0.001); and ∗∗∗indicated a significant difference in the relative expression of NF-κB between the two groups (t = 41.441, P<0.001).


## 3.5. MRNA Expression of TLR4, MyD88, and NF-κB in Child Patients’ Prepuce Tissue

Compared with the non-LSeA group, the mRNA expression of TLR4, MyD88, and NF-κB was increased in the LSeA group P<0.001, with the variation trend consistent with the western blot results (see Figure 2).Figure 2
MRNA expression of TLR4, MyD88, and NF-κB in child patients’ prepuce tissues (mean ± SD). Note: the horizontal axis indicated TLR4, MyD88, and NF-κB, and the vertical axis indicated the mRNA expression; the mRNA expression of TLR4, MyD88, and NF-κB in non-LSeA child patients was, respectively, 0.99 ± 0.02, 1.02 ± 0.02, and 1.12 ± 0.06; the mRNA expression of TLR4, MyD88, and NF-κB in LSeA child patients was, respectively, 2.06 ± 0.10, 1.75 ± 0.22, and 1.68 ± 0.21; ∗ indicated a significant difference in the relative expression of TLR4 between the two groups (t = 51.920, P<0.001); ∗∗ indicated a significant difference in the relative expression of MyD88 between the two groups (t = 16.179, P<0.001); and ∗∗∗ indicated a significant difference in the relative expression of NF-κB between the two groups (t = 12.859, P<0.001).


## 3.6. ROC Curve Results of LSeA Predicted by Each Index

The results showed that TLR4 had the highest AUC value (see Figure3 and Table 3).Figure 3
ROC curves of LSeA predicted by each index.Table 3
ROC curve results of LSeA predicted by each index.
Test result variableAUCSEaAsymp.sigbAsymp.95%CILower limitUpper limitTLR40.8230.0540.0000.7180.929MyD880.7070.0640.0000.5810.833NF-κB0.7360.0610.0000.6160.855


## 3.7. Adverse Reactions

During the treatment, 2 patients had burning sensation and 3 patients had nausea in the LSeA group, and the total incidence rate of adverse reactions was 6.58% (5/76).


## 4. Discussion

LSeA is a chronic inflammatory disease most commonly found in the external genitalia and concerns many clinical disciplines. Clinically, it is characterized by atrophic white plaques on the genital area, with the glans and foreskin being the main sites involved, which usually occurs in adults. Foreign scholars [15] believe that the incidence of this disease in boys is about 30–40%, which will lead to secondary pathological phimosis in boys, with the clinical manifestations of pruritus of the glans penis or prepuce accompanied by local depigmentation and dermatauxe and local angiotelectasis in some cases, resulting in destructive fibrotic proliferation at the lesion site, involving the glans, urethral orifice, and even the anterior urethra, and thus causing the stricture of urethral orifice and poor urination in children, which seriously affect their quality of life. LSeA usually presents as a chronic, insidiously progressive disease without obvious early symptoms, and as the disease progresses, milky white patches appear in the inner plate of prepuce and glans, and large quantities of purulent secretions are secreted, with accompanying stinging and burning sensation. It has been documented [16] that there is a potential exacerbation risk of LSeA, and the phimosis and accumulated smegma caused by it are important carcinogenic factors, and therefore, close attention should be paid to LSeA. Redundant circumcision is currently the main surgical procedure for the treatment of LSeA [17], which can effectively relieve the irritation of moist environment and urine and reduce the inflammatory reaction of the glans to some extent, but most patients still develop much urethral mouth secretions and local peeling and have slow recovery processes. Some reports in China pointed out that [18] the clinical symptoms after redundant circumcision can be improved by applying topical drugs locally, such as erythromycin ointment and tetracycline ointment, but such drugs may lead to local irritative symptoms and allergic reactions after use. As a topical drug, mometasone furoate cream can effectively treat the associated symptoms caused by lichen sclerosus of the vulva by reducing vascular permeability and exerting the effects of local anti-inflammation, antiepidermal proliferation, and vasoconstriction to improve skin lesions [19]. The results of this study showed that the total clinical efficacy rate of applying mometasone furoate cream in treating LSeA child patients was up to 90.79%, because mometasone furoate cream is an intermediate-acting corticosteroid hormone with anti-inflammatory and anti-allergic effects and has rapid onset, good effect of relieving itching, and low rate of transdermal absorption, which has been widely applied in pediatric skin disorders. Previous clinical studies have shown [20] that lesional skin sites in LSeA child patients are often accompanied by infiltration of inflammatory cells, which promotes disease development. TNF-α is produced by activated mononuclear phagocyte and can promote neutropenia adhesion to endothelial cells, stimulating local inflammatory responses in the body. IL-17 leads to inflammation and tissue damage by acting on endothelial cells, macrophages, and epithelial cells, and IL-6 is important in the inflammatory response [21], which can induce the production of C-reactive protein (CRP) and procalcitonin (PCT), directly related to the inflammatory disease and the degree of infection. The study results showed that after treatment, the levels of various inflammatory factors in LSeA child patients were significantly lower than before treatment P<0.001, indicating that mometasone furoate cream could effectively reduce the inflammatory reactions in LSeA patients, which is of great significance in improving disease prognosis.TLR4 in the TLR family plays a key role in immune inflammatory responses and is an upstream key factor in the body’s innate immune response, and MyD88 is an adaptor protein of TLRs and a downstream factor of TLR4, which is dominant in signal transduction [22]. TLR4, when activated, interacts with downstream MyD88, causes MyD88 activation, and transmits the signal to downstream, which is then phosphorylated by kinases to activate the NF-κB signaling pathway, thereby promoting the release of inflammatory factors such as TNF-α and IL-6. TLR4/MyD88/NF-κB pathway, as an inflammatory activating or innate immune pathway, has been demonstrated in various diseases such as atherosclerosis, depression after ischemic stroke, and ulcerative colitis [23]. Numerous studies have shown [24] that the TLR4 signaling pathway plays an important role in human inflammatory responses, in which TLR4 can produce various inflammatory mediators and factors through its downstream MyD88-dependent as well as MyD88-independent signal transduction pathways. MyD88 and TRAF-6 are the molecules involved in intracellular signaling in the MyD88-dependent pathway, which, after a series of signaling events, activate MAPK and NF-kB signaling pathways, leading to the expression of proinflammatory cytokines IL-6 and IL-1β and TNF-α and then evoking inflammatory responses [25]. In this study, the postoperative protein expression levels of TLR4 and MyD88 of the prepuce tissues in child patients were detected by using BCA protein assay and western blot, and it was found that both TLR4 and MyD88 showed high expression in the prepuce tissues of LSeA children, which was due to TLR4 participating in LSeA pathological responses by mediating MyD88, and the injurious factors in the body of children together with lipopolysaccharide could promote TLR4 signaling and then activate its downstream signal MyD88, thereby promoting the release of inflammatory factors and chemotactic factors in the lesional skin, which, in turn, could promote the activation of NF-κB, forming a vicious cycle and leading to the exacerbation of the disease.In conclusion, treating LSeA boys with mometasone furoate cream has good efficacy and high safety. The pathogenesis of LSeA may be attributed to the upregulation of TLR4, MyD88, NF-κB expression and thus activation of TLR4/MyD88/NF-κB signaling pathways involved.



---

*Source: 3495099-2022-03-31.xml*